Cagrilintide 10 mg

WHAT IS CAGRILINTIDE 10 MG?

Cagrilintide 10 mg is a long-acting amylin analogue designed for the regulation of appetite and body weight. It mimics the action of the endogenous hormone amylin, which is co-secreted with insulin and plays a key role in slowing gastric emptying and promoting satiety. This research peptide is gaining attention as a potential therapeutic tool in weight management protocols.

POTENTIAL RESEARCH BENEFITS

• Supports reduced appetite and food intake
• Delays gastric emptying for prolonged fullness
• May help regulate body weight and fat mass
• Complements other peptides like Semaglutide in dual therapy

HOW CAGRILINTIDE WORKS

Cagrilintide binds to the amylin receptor complex in the brain to promote satiety signals and reduce caloric intake. It is structurally modified to extend its half-life, making it suitable for once-weekly administration in research settings.

RECOMMENDED USAGE

• Dosage: 0.3–2.4 mg, titrated weekly based on response
• Administration: Subcutaneous injection
• Cycle: Often paired with GLP-1 analogs in long-term metabolic studies

STACKING OPTIONS

Researchers often stack Cagrilintide with peptides that work synergistically for enhanced metabolic results:

• Semaglutide – GLP-1 agonist to improve insulin sensitivity
• Mazdutide – GIP/GLP-1 dual agonist
• Survodutide – Glucagon/GLP-1 receptor dual agonist

BUY COGRILINTIDE FOR RESEARCH

Explore high-quality peptides from a trusted peptide supplier with fast US delivery. Cagrilintide 10 mg is available for research purposes only and is shipped securely from Peptide Hubs' domestic warehouse.

EXTERNAL LINK

For more scientific information, view the Cagrilintide listing on PubChem.

FAQ